Electrical Immunoassays toward Clinical Diagnostics: Identification of Vulnerable Cardiovascular Plaque

JALA - Journal of the Association for Laboratory Automation

Volumn 13, Issue 1, 2008, Pages 33-39

  Reddy, R K K ^a   Prasad, S ^a,b   Barrett, T ^c   Carruthers, J ^a  

^a PORTLAND STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

electrical immunoassays; nanomembranes; protein sensors

Indexed keywords

ANTIBODIES; ANTIGENS; BIOMARKERS; DIAGNOSIS; PROTEINS;

ELECTRICAL IMMUNOASSAYS; NANOMEMBRANES; PROTEIN SENSORS;

IMMUNOSENSORS;

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOPLASTIN;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ARTIFICIAL MEMBRANE; ATHEROSCLEROTIC PLAQUE; BIOSENSOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTRIC CONDUCTIVITY; ELECTROCHEMICAL DETECTION; ELECTROIMMUNOASSAY; NON INVASIVE MEASUREMENT; PERIOPERATIVE PERIOD; POROSITY; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SIGNAL NOISE RATIO; TECHNOLOGY;

EID: 37549023769     PISSN: 15355535     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2007.10.004     Document Type: Article

References (20)

1. Mangano D.T. Perioperative medicine: NHLBI working group deliberations and recommendations. J. Cardiothorac. Vasc. Anesth. 18 1 (2004) 1-6
2. Mangano D.T., Browner W.S., Hollenberg M., London M.J., Tubau J.F., and Tateo I.M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research group. N. Engl. J. Med. 323 26 (1990) 1781-1788
3. Mangano D.T., Hollenberg M., Fegert G., et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery-I: Incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J. Am. Coll. Cardiol. 17 4 (1991) 843-850
4. Mangano D.T., Wong M.G., London M.J., Tubau J.F., and Rapp J.A. Perioperative myocardial ischemia in patients undergoing noncardiac surgery-II: Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group. J. Am. Coll. Cardiol. 17 4 (1991) 851-857
5. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N. Engl. J. Med. 335 23 (1996) 1713-1720
6. Wallace A., Layug B., Tateo I., et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 88 1 (1998) 7-17
7. Brady A.R., Gibbs J.S., Greenhalgh R.M., Powell J.T., and Sydes M.R. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J. Vasc. Surg. 41 4 (2005) 602-609
8. Juul A.B., Wetterslev J., Kofoed-Enevoldsen A., Callesen T., Jensen G., and Gluud C. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am. Heart J. 147 4 (2004) 677-683
9. Mangano D.T., Browner W.S., Hollenberg M., Li J., and Tateo I.M. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 268 2 (1992) 233-239
10. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N. Engl. J. Med. 341 24 (1999) 1789-1794
11. Nettleman M.D., Banitt L., Barry W., Awan I., and Gordon E.E. Predictors of survival and the role of gender in postoperative myocardial infarction. Am. J. Med. 103 5 (1997) 357-362
12. Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 10 (1999) 1043-1049
13. Kertai M.D., Boersma E., Klein J., Van Urk H., Bax J.J., and Poldermans D. Longterm prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur. J. Vasc. Endovasc. Surg. 28 1 (2004) 59-66
14. Leach C., and Bach R.G. Atherosclerotic coronary plaque in a patient with the metabolic syndrome: assessment by lesion physiology and intravascular ultrasound virtual histology. J. CardioMetabol. Syndr. 1 3 (2006) 225-227
15. Norja S., Nuutila L., Karhunen P.J., and Goebeler S. C-reactive protein in vulnerable coronary plaques. J. Clin. Pathol. 60 (2007) 545-548
16. Shiina, T.; Nitta, N.; Endo, H.; Yamagishi, M. Assessment of vulnerable coronary plaque by intravascular elasticity imaging. IEEE Ultrasonics Symposium 2004, 1(1), 364-367.
17. Casscells W., Hathorn B., David M., et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 347 9013 (1996) 1447-1451
18. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: metaanalyses of prospective studies. JAMA 279 18 (1998) 1477-1482
19. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347 20 (2002) 1557-1565
20. Li F., Zhang L., and Metzger R.M. On the growth of highly ordered pores in anodized aluminum oxide. Chem. Mater. 10 (1998) 2470-2480